A new initiative aimed at assessing a blood test for the early detection of pancreatic cancer is now recruiting participants. The Safe-D study, taking place in Southampton is enrolling individuals with type 2 diabetes — a condition linked to an increased risk of developing pancreatic cancer. It is supported by Wessex Health Partners, a regional partnership bringing together Integrated Care…
Ben KempJune 17, 2025